231 related articles for article (PubMed ID: 22129109)
1. Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine.
Huang YL; Pang VF; Lin CM; Tsai YC; Chia MY; Deng MC; Chang CY; Jeng CR
Vet Res; 2011 Dec; 42(1):115. PubMed ID: 22129109
[TBL] [Abstract][Full Text] [Related]
2. Porcine circovirus type 2 decreases the infection and replication of attenuated classical swine fever virus in porcine alveolar macrophages.
Huang YL; Pang VF; Deng MC; Chang CY; Jeng CR
Res Vet Sci; 2014 Feb; 96(1):187-95. PubMed ID: 24370262
[TBL] [Abstract][Full Text] [Related]
3. The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications.
Chen JY; Wu CM; Liao CM; Chen KC; You CC; Wang YW; Huang C; Chien MS
Vaccine; 2019 Oct; 37(43):6535-6542. PubMed ID: 31500966
[TBL] [Abstract][Full Text] [Related]
4. Impact of porcine reproductive and respiratory syndrome virus and porcine circovirus-2 infection on the potency of the classical swine fever vaccine (LOM strain).
Lim SI; Jeoung HY; Kim B; Song JY; Kim J; Kim HY; Cho IS; Woo GH; Lee JB; An DJ
Vet Microbiol; 2016 Sep; 193():36-41. PubMed ID: 27599928
[TBL] [Abstract][Full Text] [Related]
5. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
[TBL] [Abstract][Full Text] [Related]
6. A prospective CSFV-PCV2 bivalent vaccine effectively protects against classical swine fever virus and porcine circovirus type 2 dual challenge and prevents horizontal transmission.
Chen JY; Wu CM; Chia MY; Huang C; Chien MS
Vet Res; 2023 Jul; 54(1):57. PubMed ID: 37434231
[TBL] [Abstract][Full Text] [Related]
7. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
8. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
[TBL] [Abstract][Full Text] [Related]
9. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.
Park C; Oh Y; Seo HW; Han K; Chae C
Clin Vaccine Immunol; 2013 Mar; 20(3):369-76. PubMed ID: 23302743
[TBL] [Abstract][Full Text] [Related]
11. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
Opriessnig T; Xiao CT; Halbur PG; Gerber PF; Matzinger SR; Meng XJ
Vaccine; 2017 Jan; 35(2):248-254. PubMed ID: 27919634
[TBL] [Abstract][Full Text] [Related]
12. Secreted Expression of the Cap Gene of Porcine Circovirus Type 2 in Classical Swine Fever Virus C-Strain: Potential of C-Strain Used as a Vaccine Vector.
Zhang L; Li Y; Xie L; Wang X; Gao X; Sun Y; Qiu HJ
Viruses; 2017 Oct; 9(10):. PubMed ID: 29035292
[TBL] [Abstract][Full Text] [Related]
13. Investigation of chronic and persistent classical swine fever infections under field conditions and their impact on vaccine efficacy.
Coronado L; Bohórquez JA; Muñoz-González S; Perez LJ; Rosell R; Fonseca O; Delgado L; Perera CL; Frías MT; Ganges L
BMC Vet Res; 2019 Jul; 15(1):247. PubMed ID: 31307464
[TBL] [Abstract][Full Text] [Related]
14. CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.
Renson P; Le Dimna M; Keranflech A; Cariolet R; Koenen F; Le Potier MF
Vet Res; 2013 Feb; 44(1):9. PubMed ID: 23398967
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
Park C; Jeong J; Choi K; Chae C
Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a live attenuated vaccine in classical swine fever virus postnatally persistently infected pigs.
Muñoz-González S; Perez-Simó M; Muñoz M; Bohorquez JA; Rosell R; Summerfield A; Domingo M; Ruggli N; Ganges L
Vet Res; 2015 Jul; 46(1):78. PubMed ID: 26159607
[TBL] [Abstract][Full Text] [Related]
17. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines.
Seo HW; Han K; Park C; Chae C
Vet J; 2014 Apr; 200(1):65-70. PubMed ID: 24618398
[TBL] [Abstract][Full Text] [Related]
18. Effect of Maternal Antibody Transfer on Antibody Dynamics and Control of Porcine Circovirus Type 2 Infection in Offspring.
Dvorak CMT; Payne BJ; Seate JL; Murtaugh MP
Viral Immunol; 2018; 31(1):40-46. PubMed ID: 28817375
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge.
Oh Y; Seo HW; Park C; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):371-80. PubMed ID: 24970364
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
